H. Lundbeck A/S (HLBBF)
OTCMKTS · Delayed Price · Currency is USD
6.83
0.00 (0.00%)
At close: Dec 11, 2025
H. Lundbeck Market Cap
H. Lundbeck has a market cap or net worth of $6.48 billion as of December 16, 2025. Its market cap has increased by 9.00% in one year.
Market Cap
6.48B
Enterprise Value
7.89B
Revenue
3.78B
Ranking
n/a
PE Ratio
10.83
Stock Price
$6.83
Market Cap Chart
Since June 10, 2022, H. Lundbeck's market cap has increased from 4.54B to 6.48B, an increase of 42.79%. That is a compound annual growth rate of 10.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 6.48B | 18.13% |
| Dec 30, 2024 | 5.49B | 16.62% |
| Dec 29, 2023 | 4.70B | 28.73% |
| Dec 30, 2022 | 3.65B | -19.48% |
| Jun 10, 2022 | 4.54B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 849.79M |
| Glass House Brands | 789.81M |
| Elite Pharmaceuticals | 534.83M |
| CytoDyn | 398.68M |
| Northwest Biotherapeutics | 376.54M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 311.74M |
| Nika Pharmaceuticals | 285.90M |